Xuekun Yao

Title: Xuekun Yao: Innovator in Cancer Treatment

Introduction

Xuekun Yao is a notable inventor based in Hebei, China. He has made significant contributions to the field of oncology through his innovative research and development of pharmaceutical preparations.

Latest Patents

Xuekun Yao holds a patent for the "Use of mitoxantrone liposome for treating non-Hodgkin's lymphoma." This patent discloses the use of a liposomal pharmaceutical preparation of mitoxantrone in the creation of a medicament specifically for treating lymphoma. The focus is on non-Hodgkin's lymphoma, particularly aggressive forms such as diffuse large B-cell lymphoma or peripheral T-cell lymphoma. The invention emphasizes the use of mitoxantrone liposomes as a single anti-tumor therapeutic agent, without the need for combination with other anti-tumor agents. He has 1 patent to his name.

Career Highlights

Xuekun Yao is associated with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., where he continues to advance his research in cancer treatment. His work has the potential to significantly impact the therapeutic landscape for patients suffering from lymphoma.

Collaborations

Some of his notable coworkers include Chunlei Li and Yueying Peng, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Xuekun Yao's innovative work in the development of mitoxantrone liposomes represents a promising advancement in the treatment of non-Hodgkin's lymphoma. His contributions to oncology are noteworthy and reflect his commitment to improving patient outcomes.